Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System

计划入组 66 人 · 首次发布于 2022 年 6 月 23 日

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

计划入组 250 人 · 首次发布于 2021 年 8 月 24 日

Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease

计划入组 50 人 · 首次发布于 2021 年 6 月 15 日

CSA-92

LSP-92

NJA-92

Route 92 Medical, Inc.

United States

ICU Medical, Inc.

United States

Aethlon Medical

Route 92 Medical Wins Patent Litigation Settlement: Q'Apel Permanently Removes Competing Neurovascular Product

Route 92 Medical Secures $50 Million Growth Financing to Expand Revolutionary Stroke Treatment Technology

Route 92 Medical's HiPoint 88 Reperfusion System Achieves Record First Pass Effect in Stroke Thrombectomy Trial